CD9 exacerbates pathological cardiac hypertrophy through regulating GP130/STAT3 signalling pathway

Yue Li(First Affiliated Hospital of Zhengzhou University), Zhibo Liu(Beijing National Laboratory for Molecular Sciences)

Research Square

September 21, 2022

10.21203/rs.3.rs-2004988/v1

Cited by 0

Related Papers

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

|The Lancet|2020|3.7k

A corrosion-resistant RuMoNi catalyst for efficient and long-lasting seawater oxidation and anion exchange membrane electrolyzer

|Nature Communications|2023|483

Prolonged sleep deprivation induces a cytokine-storm-like syndrome in mammals

|Cell|2023|236

A highly active and durable electrocatalyst for large current density hydrogen evolution reaction

|Science Bulletin|2019|84

Photocatalytic direct borylation of carboxylic acids

|Nature Communications|2022|38